Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for Traumatic Nerve Fiber Injuries
NCT03336996Unknown
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of human umbilical cord mesenchymal stem cells in traumatic nerve injury (PNI), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Blood Oxygen Level-Dependent Functional Magnetic Resonance Imaging Derived Diffusion Tensor Imaging Scanning at 6 months. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
traumatic nerve injury (PNI)
Beyond the preview
Go deeper on NCT03336996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336996.